Effetto antidepressivo della tossina botulinica. Cosa dice la scienza

BIBLIOGRAFIA

1. Botulinum Neurotoxin Type A in Neurology: Update. Orsini M, Leite MA, Chung TM, Bocca W, de Souza JA, de Souza OG, Moreira RP, Bastos VH, Teixeira S, Oliveira AB, Moraes Bda S, Matta AP, Jacinto LJ.Neurol Int. 2015 Sep 24
2. Effects of botulinum toxin type a on mood and cognitive function in patients with parkinson’s disease and depression. Zhu C, Wang K, Yu T, Liu H.Am J Transl Res. 2021 Apr
3. Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice.Begasse de Dhaem O, Gharedaghi MH, Rizzoli P.Headache. 2020 Jul
4. An update on the neurologic applications of botulinum toxins. Evidente VG, Adler CH.Curr Neurol Neurosci Rep. 2010 Sep
5. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Pirazzini M, Rossetto O, Eleopra R, Montecucco C.Pharmacol Rev. 2017 Apr
6. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J.Toxicon. 2013 Jun
7. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.Del Sorbo F, Albanese A.Toxicon. 2015 Dec
8. Treatment of depression with botulinum toxin A: a case series.Finzi E, Wasserman E.Dermatol Surg. 2006 May
9. The safety and efficacy of botulinum toxin A on the treatment of depression. Zhang Q, Wu W, Fan Y, Li Y, Liu J, Xu Y, Jiang C, Tang Z, Cao C, Liu T, Chen LH, Hu H, Luo W.Brain Behav. 2021 Sep
10. Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective. Li Y, Liu T, Luo W.Front Psychiatry. 2021 Apr
11. Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry. Finzi E.Toxins (Basel). 2023 May
12. Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective. Li Y, Liu T, Luo W.Front Psychiatry. 2021 Apr
13. Impact of botulinum toxin for facial aesthetics on psychological well-being and quality of life: Evidence-based review. Pereira IN, Hassan H.J Plast Reconstr Aesthet Surg. 2022 Dec
14. Botulinum Toxin Injections for Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape. Demchenko I, Swiderski A, Liu H, Jung H, Lou W, Bhat V.Toxins (Basel). 2024 Apr 
15. OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females.Brin MF, Durgam S, Lum A, James L, Liu J, Thase ME, Szegedi A.Int Clin Psychopharmacol. 2020 Jan
16. Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Qian H, Shao F, Lenahan C, Shao A, Li Y.Front Psychiatry. 2020 Dec 4;11
17. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.Magid M, Reichenberg JS, Poth PE, Robertson HT, LaViolette AK, Kruger TH, Wollmer MA.J Clin Psychiatry. 2014 Aug
18. Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial.Finzi E, Rosenthal NE.J Psychiatr Res. 2014 May
19. Facing depression with botulinum toxin: a randomized controlled trial. Wollmer MA, de Boer C, Kalak N, Beck J, Götz T, Schmidt T, Hodzic M, Bayer U, Kollmann T, Kollewe K, Sönmez D, Duntsch K, Haug MD, Schedlowski M, Hatzinger M, Dressler D, Brand S, Holsboer-Trachsler E, Kruger TH.J Psychiatr Res. 2012 May
20. Facial aesthetics: is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials.Gadhia K, Walmsley AD.Br Dent J. 2009 Sep
21. Role of Botulinum Toxin in Depression.Parsaik AK, Mascarenhas SS, Hashmi A, Prokop LJ, John V, Okusaga O, Singh B.J Psychiatr Pract. 2016 Mar
22. Antidepressant-Like Action of Single Facial Injection of Botulinum Neurotoxin A is Associated with Augmented 5-HT Levels and BDNF/ERK/CREB Pathways in Mouse Brain. Li Y, Liu J, Liu X, Su CJ, Zhang QL, Wang ZH, Cao LF, Guo XY, Huang Y, Luo W, Liu T.Neurosci Bull. 2019 Aug
23. The link between facial feedback and neural activity within central circuitries of emotion–new insights from botulinum toxin-induced denervation of frown muscles.Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschläger AM, Haslinger B.Cereb Cortex. 2009 Mar
24. Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design.Kim MJ, Neta M, Davis FC, Ruberry EJ, Dinescu D, Heatherton TF, Stotland MA, Whalen PJ.Biol Mood Anxiety Disord. 2014 Oct
25. Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China. Li Y, Zhu T, Shen T, Wu W, Cao J, Sun J, Liu J, Zhou X, Jiang C, Tang Z, Liu T, Chen L, Hu H, Luo W.J Affect Disord. 2022 Dec
26. Botulinum toxin in the treatment of resistant depressive disorder: Comparison of 2 facial injection sites, Caroline Ceolato, Eric Charles, Jean-Pierre Clément Danièle Ranoux, Toxicon, 2018
27. Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial., Wollmer MA, Kalak N, Jung S, de Boer C, Magid M, Reichenberg JS, Brand S, Holsboer-Trachsler E, Kruger TH.Front Psychiatry. 2014 Mar 
28. Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Magid M, Finzi E, Kruger TH, Robertson HT, Keeling BH, Jung S, Reichenberg JS, Rosenthal NE, Wollmer MA. Pharmacopsychiatry. 2015 Sep
29. Depression–An emerging indication for botulinum toxin treatment., Kruger TH, Wollmer MA.Toxicon. 2015 Dec
30. Treatment of Depression with Botulinum Toxin. Wollmer MA, Magid M, Kruger THC, Finzi E.Toxins (Basel). 2022 May
31. Depression–An emerging indication for botulinum toxin treatment. Kruger TH, Wollmer MA.Toxicon. 2015 Dec
32. Can Botulinum Toxin Help Patients With Borderline Personality Disorder? Kruger TH, Magid M, Wollmer MA.Am J Psychiatry. 2016 Sep
33. Botulinum toxin for depression: Does patient appearance matter? Reichenberg JS, Hauptman AJ, Robertson HT, Finzi E, Kruger TH, Wollmer MA, Magid M.J Am Acad Dermatol. 2016 Jan
34. Mirror neuron system.Rajmohan V, Mohandas E.Indian J Psychiatry. 2007 Jan
35. OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females. Brin MF, Durgam S, Lum A, James L, Liu J, Thase ME, Szegedi A.Int Clin Psychopharmacol. 2020 Jan
36. Botulinum Toxin Type-A (BoNT-A) Injections of the Corrugator Muscles for Aesthetics and Depression?Brennan, Connie RN, Plastic Surgical Nursing October/December 2016. 
37. Botulinum toxin therapy of bipolar depression: A case series.Finzi E, Kels L, Axelowitz J, Shaver B, Eberlein C, Krueger TH, Wollmer MA.J Psychiatr Res. 2018 Sep
38. Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial.Wollmer MA, Neumann I, Jung S, Bechinie A, Herrmann J, Müller A, Wohlmuth P, Fournier-Kaiser L, Sperling C, Peters L, Kneer J, Engel J, Jürgensen F, Schulze J, Nagel M, Prager W, Sinke C, Kahl KG, Karst M, Dulz B, Kruger THC.J Psychopharmacol. 2022 Feb
39. Botulinum Toxin Therapy of Social Anxiety Disorder: A Case Series. Finzi E, Rosenthal NE.J Clin Psychopharmacol. 2019 Jul/Aug